Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Nadim Yared
AddedMar 31, 2024
UpdatedMay 31, 2026
Nadim Yared

Nadim Yared

Board Member, Cvrx

CrunchbaseLinkedIn

Nadim Yared's Career

Cvrx
Cvrx

Minneapolis, MN, US

Board Member· Board
Nanowear
Nanowear

New York City, NY, US

Board Member· Board
Intio
Intio

Broomfield, CO, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Nadim Yared's Career

Cvrx
Cvrx
Public$390.6M1602001Minneapolis, MN, US
Board Member· Board

Leadership at Cvrx

Mudit K JainMudit K JainBoard Member
Jim ShapiroJim ShapiroBoard Member
Josep Ll. SanfeliuJosep Ll. SanfeliuBoard Member
Joseph P. SlatteryJoseph P. SlatteryBoard Member
Geoff PardoGeoff PardoBoard Member
John M NehraJohn M NehraBoard Member

Similar to Cvrx

BarologicsBarologicsCarver, MN, USMedical Devicesest. 2017BarologicsCarver, MN, US · est. 2017

Innovative medical tech company in Carver, MN treating hypertension with disruptive technology.

Series A · $11.5M6
CardieXCardieXItasca, IL, USHealthcare, Medical Devicesest. 2005CardieXItasca, IL, US · est. 2005

CardieX: A global health tech firm specializing in hypertension and cardiovascular disease solutions.

Public · $75k36
Vascular DynamicsVascular DynamicsMountain View, CA, USMedical Devices, Stentsest. 2008Vascular DynamicsMountain View, CA, US · est. 2008

Vascular Dynamics: US-based medical product provider specializing in stent implants for hypertension.

Series B · $105.1M24
MvrxMvrxBelmont, CA, USMedical Devicesest. 2009MvrxBelmont, CA, US · est. 2009

MVRx: A medical device company offering ARTO System, an innovative therapy for heart failure and mitral valve regurgitation.

Series A · $5.9M30
Nanowear
Nanowear
Seed$1.5M242014New York City, NY, US
Board Member· Board

Leadership at Nanowear

Venk VaradanVenk VaradanFounder

Similar to Nanowear

Wireless Diagnostic SystemsWireless Diagnostic SystemsSan Diego, CA, USMedical Devicesest. 2014Wireless Diagnostic SystemsSan Diego, CA, US · est. 2014

Wireless Diagnostic Systems: Pioneering nanosensor technology for patient monitoring devices.

Pre-Seed · $1.2M5
GraphWear TechnologiesGraphWear TechnologiesSan Francisco, CA, USHealth Monitoringest. 2015GraphWear TechnologiesSan Francisco, CA, US · est. 2015

Pioneering needle-free continuous health monitoring platform globally.

Series B · $25.2M29
NanopathNanopathCambridge, MA, USDiagnostics, Womens Healthest. 2019NanopathCambridge, MA, US · est. 2019

Nanopath: A molecular diagnostics firm revolutionizing testing for women's health in a single visit.

Series A · $10.3M30
NanoInnovationsNanoInnovationsSugar Land, TX, USHealthcare Analyticsest. 2011NanoInnovationsSugar Land, TX, US · est. 2011

Nanoinnovations: R&D company specializing in smart nanosensors for healthcare analytics.

Angel · $267.2k7
Intio
Intio
Pre-Seed$12.7M302005Broomfield, CO, US
Board Member· Board

Leadership at Intio

Kinney JohnsonKinney JohnsonBoard Member
Morgan NieldsMorgan NieldsBoard Member
Scott PeairsScott PeairsBoard Member
Dave GustafsonDave GustafsonFounder

Similar to Intio

Curantis SolutionsCurantis SolutionsAddison, TX, USSoftwareest. 2014Curantis SolutionsAddison, TX, US · est. 2014

Curantis Solutions: Empowering hospice and palliative caregivers with essential tools and support.

Angel · $1M52
EndueEndueNew York City, NY, USHealthcare, Softwareest. 2021EndueNew York City, NY, US · est. 2021

Modern technology provider for infusion centers, dedicated to serving those who serve others.

Seed · $3M4
Sanus SolutionsSanus SolutionsAtlanta, GA, USMedical Softwareest. 2017Sanus SolutionsAtlanta, GA, US · est. 2017

Sanus Solutions: AI-powered medical software for real-time monitoring and prevention of surgical infections.

Seed · $20k2
InterKnowlogyInterKnowlogyCarlsbad, CA, USSoftwareest. 1999InterKnowlogyCarlsbad, CA, US · est. 1999

InterKnowlogy: A software tech company specializing in Microsoft-based solutions.

Seed · $82.5k26

Nadim Yared's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to Nadim Yared

Michael RoweMichael RoweBoard Member · Hyperion DeFiChristopher BodineChristopher BodineBoard Member · OneWater MarineNeeraj ShahNeeraj ShahCEO · CureSquareNavid AlipourNavid AlipourCo-Founder · Analytics VenturesKen MaleKen MaleBoard Member · TheInfoProHank ThomasHank ThomasBoard Member · Strategic Cyber Ventures